Cite
HARVARD Citation
Vogel, A. et al. (2018). PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study. European journal of cancer. pp. 11-19. [Online].